Pharmacological profiles of the novel analgesic M58996 in rat models of persistent and neuropathic pain

Journal of Pharmacological Sciences

Volumn 102, Issue 2, 2006, Pages 205-212

  Akada, Yasushige ^a   Mori, Reiko ^a   Matsuura, Kazuyuki ^a   Suzuki, Kazuhiro ^a   Kato, Kazuo ^a   Kamiya, Masatsugu ^a   Naba, Hiroyasu ^a   Kurokawa, Misao ^a   Ogihara, Takuo ^a   Kato, Yutaka ^a   Yamasaki, Fumiaki ^a   Yamamoto, Ichiro ^a  

^a MOCHIDA PHARMACEUTICAL CO   (Japan)

Author keywords

5 HT3 receptor; Allodynia; Formalin test; GABAA receptor; Neuropathic pain

Indexed keywords

4 [N [1 [2 (4 CYANOPHENYL)ETHYL] 4 HYDROXYPIPERIDIN 4 YLMETHYL] N METHYLAMINO]BENZOIC ACID; ANALGESIC AGENT; BICUCULLINE; M 58996; NALOXONE; PERTUSSIS TOXIN; SEROTONIN 3 ANTAGONIST; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SYNTHESIS; LOCOMOTION; MALE; MOTOR PERFORMANCE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; RAT;

EID: 33750616204     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0060621     Document Type: Article

References (29)

1. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353:1959-1964.
2. Akada Y, Ogawa S, Amano K, Fukudome Y, Yamasaki F, Itoh M, et al. Potent analgesic effects of a putative sodium channel blocker M58373 on formalin-induced and neuropathic pain in rats. Eur J Pharmacol. 2006;536:248-255.
3. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109-110.
4. Dixit RK, Bhargava VK. Neurotransmitter mechanisms in gabapentin antinociception. Pharmacology. 2002;65:198-203.
5. Tseng LF, Collins KA. Pretreatment with pertussis toxin differentially modulates morphine- and β-endorphin-induced antinociception in the mouse. J Pharmacol Exp Ther. 1996;279: 39-46.
6. Akada Y, Mori R, Kato Y, Yamasaki F, Mochizuki H. Analgesic properties of the novel compound M43068 in rat models of acute and neuropathic pain. Eur J Pharmacol. 2005;523:46-53.
7. Mestre C, Pélissier T, Fialip J, Wilcox G, Eschalier A. A method to perform direct transcutaneous intrathecal injection in rats. J Pharmacol Toxicol Methods. 1994;32:197-200.
8. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33:87-107.
9. Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 1990;43:205-218.
10. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988;32:77-88.
11. Abbott FV, Franklin KBJ, Westbrook RF. The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain. 1995;60:91-102.
12. Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 1977;4:161-174.
13. Tjølsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain. 1992;51:5-17.
14. Catterall WA, Morrow CS, Daly JW, Brown GB. Binding of batrachotoxinin A 20-α-benzoate to a receptor site associated with sodium channels in synaptic nerve ending particles. J Biol Chem. 1981;256:8922-8927.
15. Kohno T, Moore KA, Baba H, Woolf CJ. Peripheral nerve injury alters excitatory synaptic transmission in lamina II of the rat dorsal horn. J Physiol. 2003;548:131-138.
16. Okamoto M, Baba H, Goldstein PA, Higashi H, Shimoji K, Yoshimura M. Functional reorganization of sensory pathways in the rat spinal dorsal horn following peripheral nerve injury. J Physiol. 2001;532:241-250.
17. Field MJ, Oles RJ, Lewis AS, McCleary S, Hughes J, Singh L. Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br J Pharmacol. 1997;121:1513-1522.
18. Hunter JC, Gogas KR, Hedley LR, Jacobson LO, Kassotakis L, Thompson J, et al. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol. 1997;324:153-160.
19. Christensen D, Gautron M, Guilbaud G, Kayser V. Effect of gabapentin and lamotrigine on mechanical allodynia-like behaviour in a rat model of trigeminal neuropathic pain. Pain. 2001;93:147-153
20. Stamford JA. Descending control of pain. Br J Anaesth. 1995;75:217-227.
21. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev. 1994;46:157-203.
22. Bardin L, Lavarenne J, Eschalier A. Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats. Pain. 2000;86:11-18.
23. Morales M, Battenberg E, deLecea L, Bloom FE. The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus. Brain Res. 1996;731:199-202.
24. 3 receptors evokes GABA release in the spinal cord. Brain Res. 2003;978:250-255.
25. 3 receptor-mediated antinociception: possible release of GABA. J Neurosci. 1991;11:1881-1888.
26. 3 receptors in periaqueductal gray-induced inhibition of nociceptive dorsal horn neurons in rats. J Pharmacol Exp Ther. 1996;276:116-124.
27. 3 receptors are involved in dorsal root reflexes: possible role in periaqueductal gray descending inhibition. J Neurophysiol. 2001;86: 49-58.
28. 3 receptor agents. Pharmacol Rev. 1991;43:579-586.
29. A receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev. 1998;50:291-313.